Clinical Guidelines and Indications
Reveal ICM Indications
The Reveal® XT and Reveal DX Insertable Cardiac Monitors are insertable patient-activated and automatically-activated monitoring systems that record subcutaneous ECG and are indicated for:
- Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias
- Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia
ESC Guidelines: Diagnosis and Management of Syncope (2009)
Class I
Insertable loop recorder (insertable cardiac monitor) is indicated in:
- An early phase of evaluation in patients with recurrent syncope of uncertain origin, absence of high risk criteria, and a high likelihood of recurrence within battery longevity of the device
- High risk patients in whom a comprehensive evaluation did not demonstrate a cause of syncope or lead to a specific treatment
Class IIa
Insertable loop recorder (insertable cardiac monitor) should be considered to assess the contribution of bradycardia before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
ESC Guidelines: Proposed Care Pathway1
References
- Crawford, M. H., S. J. Bernstein, et al. (1999). "ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology." J Am Coll Cardiol 34(3): 912-948.
- Moya, A., R. Sutton, et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)." Eur Heart J 30(21): 2631-2671.
Last updated: 26 Feb 2013
